Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Lipids

Citations 11-20 of 397 total displayed.

Past content (since Feb 1999):

Articles
Lecithin: Cholesterol Acyltransferase Expression Has Minimal Effects on Macrophage Reverse Cholesterol Transport In Vivo
Hiroyuki Tanigawa, Jeffrey T. Billheimer, Jun-ichiro Tohyama, Ilia V. Fuki, Dominic S. Ng, George H. Rothblat, and Daniel J. Rader
Circulation published June 29, 2009, doi:10.1161/CIRCULATIONAHA.108.825109 [Abstract]  

Articles
Lipid Treatment Assessment Project 2. A Multinational Survey to Evaluate the Proportion of Patients Achieving Low-Density Lipoprotein Cholesterol Goals
David D. Waters, Carlos Brotons, Cheng-Wen Chiang, Jean Ferrières, JoAnne Foody, J. Wouter Jukema, Raul D. Santos, Juan Verdejo, Michael Messig, Ruth McPherson, Ki-Bae Seung, Lisa Tarasenko for the Lipid Treatment Assessment Project 2 Investigators
Circulation published June 22, 2009, doi:10.1161/CIRCULATIONAHA.108.838466 [Abstract]  

Heart Failure
Cardiac Microvascular Pathology in Fabry Disease: Evaluation of Endomyocardial Biopsies Before and After Enzyme Replacement Therapy
Beth L. Thurberg, John T. Fallon, Richard Mitchell, Thomas Aretz, Ronald E. Gordon, and Michael W. O'Callaghan
Circulation 2009;119:2561-2567; published online before print as doi:10.1161/CIRCULATIONAHA.108.841494 [Abstract] [Full text]  

Controversies in Cardiovascular Medicine
Advanced Lipoprotein Testing and Subfractionation Are Clinically Useful
H. Robert Superko
Circulation 2009;119:2383-2395, doi:10.1161/CIRCULATIONAHA.108.809582 [Full text]  

Articles
Cardiac Microvascular Pathology in Fabry Disease. Evaluation of Endomyocardial Biopsies Before and After Enzyme Replacement Therapy
Beth L. Thurberg, John T. Fallon, Richard Mitchell, Thomas Aretz, Ronald E. Gordon, and Michael W. O'Callaghan
Circulation published May 4, 2009, doi:10.1161/CIRCULATIONAHA.108.841494 [Abstract]  

Hypertension
Vascular Smooth Muscle Cell–Selective Peroxisome Proliferator–Activated Receptor-{gamma} Deletion Leads to Hypotension
Lin Chang, Luis Villacorta, Jifeng Zhang, Minerva T. Garcia-Barrio, Kun Yang, Milton Hamblin, Steven E. Whitesall, Louis G. D'Alecy, and Y. Eugene Chen
Circulation 2009;119:2161-2169; published online before print as doi:10.1161/CIRCULATIONAHA.108.815803 [Abstract] [Full text]  

Vascular Medicine
Risk Factors for Abdominal Aortic Aneurysms: A 7-Year Prospective Study: The Tromsø Study, 1994–2001
Signe Helene Forsdahl, Kulbir Singh, Steinar Solberg, and Bjarne K. Jacobsen
Circulation 2009;119:2202-2208; published online before print as doi:10.1161/CIRCULATIONAHA.108.817619 [Abstract] [Full text]  

Articles
Risk Factors for Abdominal Aortic Aneurysms. A 7-Year Prospective Study: The Tromsø Study, 1994–2001
Signe Helene Forsdahl, Kulbir Singh, Steinar Solberg, and Bjarne K. Jacobsen
Circulation published April 13, 2009, doi:10.1161/CIRCULATIONAHA.108.817619 [Abstract]  

Articles
Vascular Smooth Muscle Cell–Selective Peroxisome Proliferator–Activated Receptor-{gamma} Deletion Leads to Hypotension
Lin Chang, Luis Villacorta, Jifeng Zhang, Minerva T. Garcia-Barrio, Kun Yang, Milton Hamblin, Steven E. Whitesall, Louis G. D'Alecy, and Y. Eugene Chen
Circulation published April 13, 2009, doi:10.1161/CIRCULATIONAHA.108.815803 [Abstract]  

Correspondence
Response to Letter Regarding Article, "Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events"
Samia Mora, Julie E. Buring, Paul M Ridker, and Nader Rifai
Circulation 2009;119:e385, doi:10.1161/CIRCULATIONAHA.108.835587 [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40

* Subspecialty Collections Home

* Show  Lipids
 collections from other journals.

* Related collections:
 Etiology
 Acute coronary syndromes
 Acute myocardial infarction
 Arrhythmias, clinical electrophysiology, drugs
 Cardiac development
 Chronic ischemic heart disease
 Clinical genetics
 Epidemiology
 Heart failure
 Hypertension
 Hypertrophy
 Infectious endocarditis
 Lipids
 Myocardial cardiomyopathy disease
 Obesity
 Pericardial disease
 Peripheral vascular disease
 Pulmonary circulation and disease
 Remodeling
 Restenosis
 Valvular heart disease
 Other etiology